IL124097A - History of trans-avincaminic acid esters, their preparation, pharmaceutical preparations containing them and their use as medicines - Google Patents

History of trans-avincaminic acid esters, their preparation, pharmaceutical preparations containing them and their use as medicines

Info

Publication number
IL124097A
IL124097A IL12409796A IL12409796A IL124097A IL 124097 A IL124097 A IL 124097A IL 12409796 A IL12409796 A IL 12409796A IL 12409796 A IL12409796 A IL 12409796A IL 124097 A IL124097 A IL 124097A
Authority
IL
Israel
Prior art keywords
formula
preparation
trans
compound
therapeutically acceptable
Prior art date
Application number
IL12409796A
Other languages
English (en)
Hebrew (he)
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of IL124097A publication Critical patent/IL124097A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D461/00Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12409796A 1995-12-22 1996-12-13 History of trans-avincaminic acid esters, their preparation, pharmaceutical preparations containing them and their use as medicines IL124097A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9503736A HU214600B (hu) 1995-12-22 1995-12-22 Transz-apovinkaminsav-észter-származékok, az azokat tartalmazó gyógyszerkészítmények és eljárás ezek előállítására
PCT/HU1996/000075 WO1997023481A1 (en) 1995-12-22 1996-12-13 Trans apovincaminic acid ester derivatives as drugs

Publications (1)

Publication Number Publication Date
IL124097A true IL124097A (en) 2001-12-23

Family

ID=10987512

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12409796A IL124097A (en) 1995-12-22 1996-12-13 History of trans-avincaminic acid esters, their preparation, pharmaceutical preparations containing them and their use as medicines

Country Status (22)

Country Link
US (1) US6093720A (es)
EP (1) EP0876367B1 (es)
JP (1) JP2000502676A (es)
KR (1) KR19990076606A (es)
CN (1) CN1072670C (es)
AR (1) AR005182A1 (es)
AT (1) ATE223914T1 (es)
AU (1) AU1166997A (es)
CA (1) CA2238635A1 (es)
CZ (1) CZ290383B6 (es)
DE (1) DE69623656T2 (es)
DK (1) DK0876367T3 (es)
ES (1) ES2181926T3 (es)
HU (1) HU214600B (es)
IL (1) IL124097A (es)
PL (1) PL186626B1 (es)
PT (1) PT876367E (es)
RU (1) RU2161157C2 (es)
TW (1) TW366348B (es)
UA (1) UA61062C2 (es)
WO (1) WO1997023481A1 (es)
ZA (1) ZA9610646B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006054536A1 (ja) * 2004-11-16 2006-05-26 Nippon Shinyaku Co., Ltd. 尿路結石症治療剤
JP2008017734A (ja) * 2006-07-11 2008-01-31 Memory Secret Inc 精神的機能を改善するための栄養補助及び栄養摂取食品用の口経投与組成物
CN102485723A (zh) * 2010-12-02 2012-06-06 江苏斯威森生物医药工程研究中心有限公司 一锅法半合成长春西汀及其水溶性盐制备
CN114920743B (zh) * 2022-05-09 2023-08-04 南京中医药大学 一种吲哚生物碱及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2531108A1 (de) * 1975-07-11 1977-02-03 Synthelabo Vincaminderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
HU186891B (en) * 1981-06-12 1985-10-28 Richter Gedeon Vegyeszet Process for producing esters of apovincaminic acid
IT1142026B (it) * 1981-07-21 1986-10-08 Ausonia Farma Srl Nuovo composto ad attivita' eumetabolica cerebrale
HU187733B (en) * 1982-06-30 1986-02-28 Richter Gedeon Vegyeszeti Gyar Rt,Hu Process for preparing apovincaminic acid derivatives
JPS60248688A (ja) * 1984-05-24 1985-12-09 Sanwa Kagaku Kenkyusho:Kk 新規のアポビンカミン酸エステルおよびその酸付加塩並びにその製造方法

Also Published As

Publication number Publication date
PL328170A1 (en) 1999-01-18
ATE223914T1 (de) 2002-09-15
CN1205701A (zh) 1999-01-20
KR19990076606A (ko) 1999-10-15
AR005182A1 (es) 1999-04-14
PL186626B1 (pl) 2004-02-27
DE69623656D1 (en) 2002-10-17
EP0876367A1 (en) 1998-11-11
RU2161157C2 (ru) 2000-12-27
HU214600B (hu) 1998-04-28
HUT76555A (en) 1997-09-29
AU1166997A (en) 1997-07-17
CZ196298A3 (cs) 1998-10-14
HU9503736D0 (en) 1996-02-28
WO1997023481A1 (en) 1997-07-03
ES2181926T3 (es) 2003-03-01
ZA9610646B (en) 1997-06-24
TW366348B (en) 1999-08-11
CA2238635A1 (en) 1997-07-03
DE69623656T2 (de) 2003-05-22
US6093720A (en) 2000-07-25
EP0876367B1 (en) 2002-09-11
UA61062C2 (en) 2003-11-17
JP2000502676A (ja) 2000-03-07
CN1072670C (zh) 2001-10-10
PT876367E (pt) 2003-01-31
DK0876367T3 (da) 2002-12-30
CZ290383B6 (cs) 2002-07-17

Similar Documents

Publication Publication Date Title
CA2197099A1 (en) Hypolipidemic 1,4-benzothiazepine-1,1-dioxides
FR2576901A1 (fr) Nouveaux derives de l'acide a-(oxo-2 hexahydro-2,4,5,6,7,7a thieno (3,2-c) pyridyl-5) phenyl acetique, leur procede de preparation et leur application therapeutique
NZ221060A (en) 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-ol derivatives and pharmaceutical compositions thereof
PT92889A (pt) Processo para a preparacao de 3-(1,2,5,6-tetra-hidropiridil)-pirrolopiridinas
FR2695126A1 (fr) Dérivés d'acide thiényl ou pyrrolyl carboxyliques, leur préparation et médicaments les contenant.
US6316439B1 (en) Galanthamine derivatives as acetylcholinesterase inhibitors
DD263774A5 (de) Verfahren zur herstellung eines neuen 1h,3h-pyrrolo-1,2-c-thiazol-derivates
FI93451C (fi) Menetelmä terapeuttisesti käyttökelpoisten /(3aS-cis)-1,2,3,3a,8,8a-heksahydropyrrolo/2,3-b/indol-5-yyli/aminokarbonyyli/karbamaattijohdannaisten valmistamiseksi
SK283536B6 (sk) Pyridylftalazindióny, spôsob ich prípravy a použitie a farmaceutické prostriedky na ich báze
SK96995A3 (en) 3-hydroxyanthranile acid derivatives, methods and intermediates products for their production, pharmaceutical compositions and their use
EP0876367B1 (en) Trans apovincaminic acid ester derivatives as drugs
EP0815110A1 (de) HALOGENIERTE $g(b)-CARBOLIN-DERIVATE, VERFAHREN ZU IHRER HERSTELLUNG UND VERWENDUNG DIESER SUBSTANZEN ZUR HEMMUNG DER ATMUNGSKETTE
CA2238625A1 (en) Delocalisation of stitch errors in the writing of gratings
Tobe et al. Synthesis and biological evaluation of CX-659S and its related compounds for their inhibitory effects on the delayed-type hypersensitivity reaction
JPH0324054A (ja) 学習・記憶力増強のための1―アシル―2―ピロリジノンおよびその組成物
JPH09249669A (ja) 縮合ピロール誘導体、およびそれらを有効成分として含有する薬剤
DE3505576A1 (de) Vorwirkstoffe entzuendungshemmender oxicame und solche vorwirkstoffe enthaltende pharmazeutische zusammensetzungen
FR2703048A1 (fr) Nouveaux composés N-Benzylpiperazine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
EP0481708A1 (en) Indenoindole compounds
Kaur et al. Design, synthesis and evaluation of benzimidazole-NsCOXis hybrids for the treatment of Alzheimer’s disease
US4753949A (en) 2-chloronicergoline having antihypoxic activity
CN118005630A (zh) 一类zak抑制剂、其制备方法及应用
US5068235A (en) Diazabicycloalkane derivative
CN117321063A (zh) 含有磷酸酯基团的化合物、包含其的药物组合物、其制备方法及其用途
Kaur et al. Design, synthesis and evaluation of benzimidazole-NsCOXis hybrids for the treatment of Alzheimer’s

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees